Alopexx

Alopexx

Concord, Massachusetts, United States
Is it you?
Investor info
Type
Venture Capital
Stage focus
  • Seed Round,
  • Early stage VC,
  • Later stage VC
Industry focus
Description
Alopexx is a clinical-stage biotechnology company developing novel monoclonal antibodies and vaccines targeting microbial antigens to prevent and treat bacterial, fungal, and parasitic infections, aiming to address antimicrobial resistance.
Previous investments
  • Company
    Amount
    Round
  • Example example company Inc
    1000000
    Investor meetings
  • Company & Company
    11000000
    Series C funding
  • Example
    524000
    Seed round A
Show more
Connected people
Email visible after logging in
  • Example Example
    Example Exampleexample[email protected]
  • Example Exampleexample
    Example Exampleexample
  • Notexample Examplenot
    Notexample Examplenotexample example[email protected]
  • Example Examplenotexample
    Example Examplenotexampleexample example[email protected]
  • Example Example
    Example Exampleexample[email protected]
  • Example Example
    Example Exampleexample[email protected]
Show more
See other investors focused on
Biotechnology
Other investors you may be interested in
Made with in San Francisco, Berlin, Valencia, Oslo, Cherkasy and Warsaw© 2015-     Foundersuite, Inc.